Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities
Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. Methods...
Saved in:
Published in | Mycoses Vol. 67; no. 5; pp. e13746 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
01.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.
Methods
We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.
Results
We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets.
Conclusion
Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls. |
---|---|
AbstractList | Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.
We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.
We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets.
Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls. BackgroundPost‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.MethodsWe prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.ResultsWe included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets.ConclusionSubjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls. Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.BACKGROUNDPost-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood.We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.METHODSWe prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose-binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA.We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets.RESULTSWe included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th-1 immune response (lower Th-1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B-cell subsets and other T lymphocyte subsets.Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls.CONCLUSIONSubjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th-1 response than controls. Background Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with PTLA develop CPA. The pathogenesis and the host immune response in subjects with PTLA who develop CPA need to be better understood. Methods We prospectively compared the innate and adaptive immune responses mounted by patients of PTLA with or without CPA (controls). We studied the neutrophil oxidative burst (by dihydrorhodamine 123 test), classic (serum C3 and C4 levels) and alternative (mannose‐binding lectin [MBL] protein levels) complement pathway, serum immunoglobulins (IgG, IgM and IgA), B and T lymphocytes and their subsets in subjects with PTLA with or without CPA. Results We included 111 subjects (58 CPA and 53 controls) in the current study. The mean ± SD age of the study population was 42.6 ± 15.7 years. The cases and controls were matched for age, gender distribution and body weight. Subjects with CPA had impaired neutrophil oxidative burst, lower memory T lymphocytes and impaired Th‐1 immune response (lower Th‐1 lymphocytes) than controls. We found no significant difference between the two groups in the serum complement levels, MBL levels, B‐cell subsets and other T lymphocyte subsets. Conclusion Subjects with CPA secondary to PTLA have impaired neutrophil oxidative burst and a lower Th‐1 response than controls. |
Author | Dhooria, Sahajal Chakrabarti, Arunaloke Arora, Kanika Muthu, Valliappan Rawat, Amit Kaur, Mandeep Agarwal, Ritesh Rudramurthy, Shivaprakash M. Chirumamilla, Naresh Kumar Sehgal, Inderpaul Singh Aggarwal, Ashutosh Nath Prasad, Kuruswamy Thurai Choudhary, Hansraj Pal, Arnab |
Author_xml | – sequence: 1 givenname: Naresh Kumar surname: Chirumamilla fullname: Chirumamilla, Naresh Kumar organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 2 givenname: Kanika surname: Arora fullname: Arora, Kanika organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 3 givenname: Mandeep surname: Kaur fullname: Kaur, Mandeep organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 4 givenname: Ritesh orcidid: 0000-0003-2547-7668 surname: Agarwal fullname: Agarwal, Ritesh organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 5 givenname: Valliappan orcidid: 0000-0003-0410-8468 surname: Muthu fullname: Muthu, Valliappan organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 6 givenname: Amit surname: Rawat fullname: Rawat, Amit organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 7 givenname: Sahajal surname: Dhooria fullname: Dhooria, Sahajal organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 8 givenname: Kuruswamy Thurai surname: Prasad fullname: Prasad, Kuruswamy Thurai organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 9 givenname: Ashutosh Nath surname: Aggarwal fullname: Aggarwal, Ashutosh Nath organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 10 givenname: Shivaprakash M. orcidid: 0000-0002-9097-9253 surname: Rudramurthy fullname: Rudramurthy, Shivaprakash M. organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 11 givenname: Arunaloke surname: Chakrabarti fullname: Chakrabarti, Arunaloke organization: Doodhadhari Burfani Hospital – sequence: 12 givenname: Hansraj surname: Choudhary fullname: Choudhary, Hansraj organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 13 givenname: Arnab orcidid: 0000-0002-0850-3118 surname: Pal fullname: Pal, Arnab organization: Postgraduate Institute of Medical Education and Research (PGIMER) – sequence: 14 givenname: Inderpaul Singh orcidid: 0000-0002-6505-6019 surname: Sehgal fullname: Sehgal, Inderpaul Singh email: inderpgi@outlook.com organization: Postgraduate Institute of Medical Education and Research (PGIMER) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38767275$$D View this record in MEDLINE/PubMed |
BookMark | eNp10c1u1DAQB3ALFdFt4cALIEtc4JDWjhN_HKsVH5WK4AAHTpEdT8CrxA6ZuKu98Qg8I0-C6RYOSPgykvXzaMb_M3ISUwRCnnJ2wcu5nA79BReqkQ_IhjfCVKxl6oRsmBGiUg1Tp-QMcccYV6aWj8ip0EqqWrUbsr-O0a5AbfTUejuv4RZomKYcgS6Ac4oISEOkmN0O-hXpPqxf6fbDFUXoU_R2OdA10Tnh-vP7jzmPU4p3d9nB0ucxYUA65viFWhfTMtkxrAHwMXk42BHhyX09J59ev_q4fVvdvH9zvb26qXrBhaxaZ6ER0lumlZVWc60Fc8ZKrUGDcpzVTnqufc8UE4PjtQFfezWYoTGs9uKcvDj2nZf0LQOu3RSwh3G0EVLGTrBWMVW3Shb6_B-6S3mJZbqiJG9bIxpT1LN7ld0EvpuXMJV9uz9fWsDLI-iXhLjA8Jdw1v2OqytxdXdxFXt5tPswwuH_sHv3eXt88QspxZgv |
Cites_doi | 10.1111/myc.12815 10.1111/myc.13553 10.1128/JCM.01821-18 10.2471/BLT.11.089441 10.1111/j.1365-2567.2009.03211.x 10.1093/infdis/jiab583 10.1183/09031936.06.00021705 10.1111/myc.12987 10.1016/j.jinf.2016.10.010 10.1111/j.1744-313X.2006.00616.x 10.2147/IDR.S403401 10.3390/jof3020026 10.1016/j.vaccine.2015.10.114 10.1093/cid/cix749 10.3389/fimmu.2021.788502 10.1093/infdis/jiu490 10.1111/1469-0691.12473 10.1016/S1473-3099(22)00057-3 10.1086/526500 10.1016/j.heliyon.2023.e15356 10.1186/1471-2334-12-144 10.4049/jimmunol.1501811 10.1183/13993003.00583-2015 10.1038/d41586-017-08280-8 10.1016/0041-3879(70)90015-2 10.1111/j.1744-313X.2011.01078.x 10.1016/j.ijregi.2022.11.005 10.1086/376526 10.1038/s41390-022-02055-2 10.2741/e406 10.1016/S0140-6736(07)61602-X 10.1016/S0041-3879(68)80002-9 10.1080/17476348.2016.1249853 10.3389/fimmu.2021.693055 10.1111/cea.12141 10.1080/17476348.2020.1750956 10.1515/CCLM.2007.033 10.1159/000234069 10.1136/thoraxjnl-2019-213606 10.1086/322791 10.1183/13993003.01184-2018 10.1038/s41586-023-06968-8 10.5005/ijcdas-53-3-137 10.1111/1469-0691.12643 |
ContentType | Journal Article |
Copyright | 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd – notice: 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM M7N 7X8 |
DOI | 10.1111/myc.13746 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1439-0507 |
EndPage | n/a |
ExternalDocumentID | 38767275 10_1111_myc_13746 MYC13746 |
Genre | researchArticle Journal Article |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OB 1OC 29M 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEGXH AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 ZXP ZZTAW ~IA ~KM ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION AEUQT AFPWT CGR CUY CVF ECM EIF LATKE NPM WRC WUP M7N 7X8 |
ID | FETCH-LOGICAL-c3136-5bae436da087a6a818830b9a688e8e7b102b6d18dc0703fb129ed2d7f9f4902d3 |
IEDL.DBID | DR2 |
ISSN | 0933-7407 1439-0507 |
IngestDate | Fri Jul 11 09:57:30 EDT 2025 Mon Jul 14 10:36:57 EDT 2025 Wed Feb 19 02:13:01 EST 2025 Tue Jul 01 04:31:06 EDT 2025 Sun Jul 06 04:45:05 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | innate immunity CPA adaptive immunity Aspergillosis TH‐1 response |
Language | English |
License | 2024 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3136-5bae436da087a6a818830b9a688e8e7b102b6d18dc0703fb129ed2d7f9f4902d3 |
Notes | Naresh Kumar Chirumamilla and Kanika Arora have contributed equally and may be considered joint first authors. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0850-3118 0000-0002-6505-6019 0000-0003-2547-7668 0000-0002-9097-9253 0000-0003-0410-8468 |
PMID | 38767275 |
PQID | 3061559349 |
PQPubID | 2045122 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_3057072576 proquest_journals_3061559349 pubmed_primary_38767275 crossref_primary_10_1111_myc_13746 wiley_primary_10_1111_myc_13746_MYC13746 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2024 2024-05-00 2024-May 20240501 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: May 2024 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Mycoses |
PublicationTitleAlternate | Mycoses |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2001; 184 1968; 49 2017; 3 2019; 53 2022; 92 2013; 43 2023; 6 2006; 33 2023; 16 2019; 57 2023; 9 2024; 626 2015; 33 2011; 53 2016; 10 2003; 37 2020; 14 1970; 51 2012; 39 2018; 61 2022; 22 2018; 66 2017; 552 2012; 12 2014; 20 1986; 80 2017; 74 2023; 66 2019; 62 2021; 12 1990; 115 2007; 370 2020; 75 2015; 211 2006; 27 2010; 130 2011; 89 2013 2012; 4 2008; 197 2007; 45 2016; 47 2022; 225 2016; 196 e_1_2_7_6_1 Kurup VP (e_1_2_7_39_1) 1990; 115 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_10_1 e_1_2_7_46_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 |
References_xml | – volume: 89 start-page: 864 issue: 12 year: 2011 end-page: 872 article-title: Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis publication-title: Bull World Health Organ – volume: 22 start-page: 1052 issue: 7 year: 2022 end-page: 1061 article-title: Efficacy of 12‐months oral itraconazole versus 6‐months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open‐label, randomised controlled trial in India publication-title: Lancet Infect Dis – volume: 57 start-page: e01821‐18 issue: 3 year: 2019 article-title: Utility of serum and Bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary Aspergillosis publication-title: J Clin Microbiol – volume: 225 start-page: 1822 issue: 10 year: 2022 end-page: 1831 article-title: Defective interferon‐gamma production is common in chronic pulmonary Aspergillosis publication-title: J Infect Dis – volume: 80 start-page: 300 issue: 3 year: 1986 end-page: 306 article-title: Class‐specific antibody determination against aspergillus fumigatus by means of the enzyme‐linked immunosorbent assay. III. Comparative study: IgG, IgA, IgM ELISA titers, precipitating antibodies and IgE binding after fractionation of the antigen publication-title: Int Arch Allergy Appl Immunol – volume: 115 start-page: 298 issue: 3 year: 1990 end-page: 303 article-title: Antibody isotype responses in aspergillus‐induced diseases publication-title: J Lab Clin Med – volume: 45 start-page: 183 issue: 2 year: 2007 end-page: 186 article-title: Distinct alleles of mannose‐binding lectin (MBL) and surfactant proteins a (SP‐A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis publication-title: Clin Chem Lab Med – volume: 37 start-page: S265 issue: Suppl 3 year: 2003 end-page: S280 article-title: Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review publication-title: Clin Infect Dis – volume: 626 start-page: 827 issue: 8000 year: 2024 end-page: 835 article-title: Smoking changes adaptive immunity with persistent effects publication-title: Nature – volume: 66 start-page: 299 issue: 4 year: 2023 end-page: 303 article-title: Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis publication-title: Mycoses – volume: 16 start-page: 2217 year: 2023 end-page: 2226 article-title: Serum cytokine biomarkers for use in diagnosing pulmonary tuberculosis versus chronic pulmonary Aspergillosis publication-title: Infect Drug Resist – volume: 61 start-page: 770 issue: 10 year: 2018 end-page: 776 article-title: Diagnostic cut‐off of aspergillus fumigatus‐specific IgG in the diagnosis of chronic pulmonary aspergillosis publication-title: Mycoses – volume: 51 start-page: 227 issue: 3 year: 1970 end-page: 245 article-title: Aspergilloma and residual tuberculous cavities—the results of a resurvey publication-title: Tubercle – volume: 62 start-page: 1108 issue: 12 year: 2019 end-page: 1115 article-title: Efficiency of a fumigatus‐specific IgG and galactomannan testing in the diagnosis of simple aspergilloma publication-title: Mycoses – volume: 12 year: 2021 article-title: The role of diverse immune cells in sarcoidosis publication-title: Front Immunol – volume: 47 start-page: 45 issue: 1 year: 2016 end-page: 68 article-title: Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management publication-title: Eur Respir J – volume: 14 start-page: 715 issue: 7 year: 2020 end-page: 727 article-title: An overview of the available treatments for chronic cavitary pulmonary aspergillosis publication-title: Expert Rev Respir Med – volume: 197 start-page: 618 issue: 4 year: 2008 end-page: 621 article-title: Polymorphisms in toll‐like receptor genes and susceptibility to pulmonary aspergillosis publication-title: J Infect Dis – volume: 552 start-page: 337 issue: 7685 year: 2017 end-page: 339 article-title: The origins of memory T cells publication-title: Nature – volume: 10 start-page: 1317 issue: 12 year: 2016 end-page: 1334 article-title: Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis publication-title: Expert Rev Respir Med – volume: 211 start-page: 651 issue: 4 year: 2015 end-page: 660 article-title: Elevated levels of the neutrophil chemoattractant pro‐platelet basic protein in macrophages from individuals with chronic and allergic aspergillosis publication-title: J Infect Dis – volume: 27 start-page: 1307 issue: 6 year: 2006 end-page: 1310 article-title: Interferon‐gamma therapy in two patients with progressive chronic pulmonary aspergillosis publication-title: Eur Respir J – volume: 49 start-page: 1 issue: 1 year: 1968 end-page: 11 article-title: Aspergillus in persistent lung cavities after tuberculosis. A report from the research committee of the British tuberculosis association publication-title: Tubercle – volume: 9 issue: 4 year: 2023 article-title: Role of serum procalcitonin in the diagnosis and monitoring of treatment response in treatment‐naïve subjects with chronic pulmonary aspergillosis publication-title: Heliyon – volume: 43 start-page: 850 issue: 8 year: 2013 end-page: 873 article-title: Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria publication-title: Clin Exp Allergy – volume: 20 start-page: O480 issue: 8 year: 2014 end-page: O488 article-title: A prominent role for the IL1 pathway and IL15 in susceptibility to chronic cavitary pulmonary aspergillosis publication-title: Clin Microbiol Infect – volume: 3 issue: 2 year: 2017 article-title: Innate and adaptive immune defects in chronic pulmonary Aspergillosis publication-title: J Fungi (Basel) – volume: 4 start-page: 651 year: 2012 end-page: 661 article-title: SP‐A and SP‐D in host defense against fungal infections and allergies publication-title: Front Biosci (Elite Ed) – volume: 53 start-page: 1801184 issue: 3 year: 2019 article-title: Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation publication-title: Eur Respir J – volume: 33 start-page: 297 issue: 4 year: 2006 end-page: 302 article-title: Cytokine profiling of pulmonary aspergillosis publication-title: Int J Immunogenet – volume: 33 start-page: 7271 issue: 51 year: 2015 end-page: 7275 article-title: Response to pneumococcal polysaccharide vaccination in patients with chronic and allergic aspergillosis publication-title: Vaccine – volume: 66 start-page: 261 issue: 2 year: 2018 end-page: 267 article-title: Pentraxin 3 gene polymorphisms and pulmonary Aspergillosis in chronic obstructive pulmonary disease patients publication-title: Clin Infect Dis – volume: 6 start-page: 7 year: 2023 end-page: 14 article-title: New estimation of the prevalence of chronic pulmonary aspergillosis (CPA) related to pulmonary TB—a revised burden for India publication-title: IJID Reg – volume: 20 start-page: O960 issue: 11 year: 2014 end-page: O968 article-title: Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT publication-title: Clin Microbiol Infect – volume: 75 start-page: 513 issue: 6 year: 2020 end-page: 516 article-title: Interferon gamma replacement as salvage therapy in chronic pulmonary aspergillosis: effects on frequency of acute exacerbation and all‐cause hospital admission publication-title: Thorax – volume: 74 start-page: 81 issue: 1 year: 2017 end-page: 88 article-title: Pulmonary immune responses against aspergillus fumigatus are characterized by high frequencies of IL‐17 producing T‐cells publication-title: J Infect – volume: 12 year: 2021 article-title: Tissue‐resident memory T cells in antifungal immunity publication-title: Front Immunol – volume: 92 start-page: 1535 issue: 6 year: 2022 end-page: 1542 article-title: Pediatric systemic lupus erythematosus: phagocytic defect and oxidase activity of neutrophils publication-title: Pediatr Res – volume: 12 year: 2012 article-title: Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis publication-title: BMC Infect Dis – volume: 196 start-page: 1272 issue: 3 year: 2016 end-page: 1283 article-title: Human neutrophils use different mechanisms to kill aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects publication-title: J Immunol – volume: 370 start-page: 1453 issue: 9596 year: 2007 end-page: 1457 article-title: The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Lancet – volume: 130 start-page: 46 issue: 1 year: 2010 end-page: 54 article-title: Anti‐aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity publication-title: Immunology – volume: 184 start-page: 653 issue: 5 year: 2001 end-page: 656 article-title: Mannose‐binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis publication-title: J Infect Dis – volume: 53 start-page: 137 issue: 3 year: 2011 end-page: 140 article-title: Allergic bronchopulmonary aspergillosis: lessons learnt from genetics publication-title: Indian J Chest Dis Allied Sci – volume: 39 start-page: 224 issue: 3 year: 2012 end-page: 232 article-title: Mannose‐binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis publication-title: Int J Immunogenet – year: 2013 – ident: e_1_2_7_3_1 doi: 10.1111/myc.12815 – ident: e_1_2_7_6_1 doi: 10.1111/myc.13553 – ident: e_1_2_7_17_1 doi: 10.1128/JCM.01821-18 – ident: e_1_2_7_4_1 doi: 10.2471/BLT.11.089441 – ident: e_1_2_7_44_1 doi: 10.1111/j.1365-2567.2009.03211.x – ident: e_1_2_7_27_1 doi: 10.1093/infdis/jiab583 – ident: e_1_2_7_40_1 doi: 10.1183/09031936.06.00021705 – ident: e_1_2_7_16_1 doi: 10.1111/myc.12987 – ident: e_1_2_7_43_1 doi: 10.1016/j.jinf.2016.10.010 – ident: e_1_2_7_14_1 doi: 10.1111/j.1744-313X.2006.00616.x – ident: e_1_2_7_32_1 doi: 10.2147/IDR.S403401 – ident: e_1_2_7_21_1 doi: 10.3390/jof3020026 – ident: e_1_2_7_29_1 doi: 10.1016/j.vaccine.2015.10.114 – ident: e_1_2_7_31_1 doi: 10.1093/cid/cix749 – ident: e_1_2_7_33_1 doi: 10.3389/fimmu.2021.788502 – ident: e_1_2_7_12_1 doi: 10.1093/infdis/jiu490 – ident: e_1_2_7_11_1 doi: 10.1111/1469-0691.12473 – ident: e_1_2_7_7_1 doi: 10.1016/S1473-3099(22)00057-3 – ident: e_1_2_7_22_1 doi: 10.1086/526500 – ident: e_1_2_7_5_1 doi: 10.1016/j.heliyon.2023.e15356 – ident: e_1_2_7_28_1 doi: 10.1186/1471-2334-12-144 – ident: e_1_2_7_37_1 doi: 10.4049/jimmunol.1501811 – ident: e_1_2_7_18_1 doi: 10.1183/13993003.00583-2015 – ident: e_1_2_7_46_1 doi: 10.1038/d41586-017-08280-8 – ident: e_1_2_7_9_1 doi: 10.1016/0041-3879(70)90015-2 – ident: e_1_2_7_26_1 doi: 10.1111/j.1744-313X.2011.01078.x – volume: 115 start-page: 298 issue: 3 year: 1990 ident: e_1_2_7_39_1 article-title: Antibody isotype responses in aspergillus‐induced diseases publication-title: J Lab Clin Med – ident: e_1_2_7_2_1 doi: 10.1016/j.ijregi.2022.11.005 – ident: e_1_2_7_13_1 doi: 10.1086/376526 – ident: e_1_2_7_20_1 doi: 10.1038/s41390-022-02055-2 – ident: e_1_2_7_30_1 doi: 10.2741/e406 – ident: e_1_2_7_15_1 doi: 10.1016/S0140-6736(07)61602-X – ident: e_1_2_7_10_1 doi: 10.1016/S0041-3879(68)80002-9 – ident: e_1_2_7_36_1 doi: 10.1080/17476348.2016.1249853 – ident: e_1_2_7_45_1 doi: 10.3389/fimmu.2021.693055 – ident: e_1_2_7_35_1 doi: 10.1111/cea.12141 – ident: e_1_2_7_19_1 doi: 10.1080/17476348.2020.1750956 – ident: e_1_2_7_24_1 doi: 10.1515/CCLM.2007.033 – ident: e_1_2_7_38_1 doi: 10.1159/000234069 – ident: e_1_2_7_42_1 – ident: e_1_2_7_41_1 doi: 10.1136/thoraxjnl-2019-213606 – ident: e_1_2_7_25_1 doi: 10.1086/322791 – ident: e_1_2_7_8_1 doi: 10.1183/13993003.01184-2018 – ident: e_1_2_7_47_1 doi: 10.1038/s41586-023-06968-8 – ident: e_1_2_7_34_1 doi: 10.5005/ijcdas-53-3-137 – ident: e_1_2_7_23_1 doi: 10.1111/1469-0691.12643 |
SSID | ssj0017926 |
Score | 2.3884456 |
Snippet | Background
Post‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with... Post-tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%-25% of the subjects with PTLA... BackgroundPost‐tuberculosis lung abnormality (PTLA) is the most common risk factor for chronic pulmonary aspergillosis (CPA), and 14%–25% of the subjects with... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | e13746 |
SubjectTerms | Adaptive Immunity Adult Age composition Aspergillosis Body weight CPA Female Helper cells Humans Immune response Immunity, Innate Immunoglobulin A Immunoglobulin G Immunoglobulin M Immunological memory innate immunity Leukocytes (neutrophilic) Lung - immunology Lymphocytes Lymphocytes T Male Mannose Memory cells Middle Aged Neutrophils Neutrophils - immunology Population studies Prospective Studies Pulmonary Aspergillosis - complications Pulmonary Aspergillosis - immunology Respiratory Burst Risk factors TH‐1 response Tuberculosis Tuberculosis, Pulmonary - complications Tuberculosis, Pulmonary - immunology Young Adult |
Title | Innate and adaptive immune responses in subjects with CPA secondary to post‐pulmonary tuberculosis lung abnormalities |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fmyc.13746 https://www.ncbi.nlm.nih.gov/pubmed/38767275 https://www.proquest.com/docview/3061559349 https://www.proquest.com/docview/3057072576 |
Volume | 67 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD6UiuCLtl5jL4zigy9Zkp1LEnzari5VqIhYqCCEuQWWrsmykyD1yZ_gb_SXOGeyCVYRxLeQTJjbuXxn5sw3AM8SnVZSGB0rmrGYCc1iVQkey8rYRBjK8woDxbO34vScvbngFzvwYjgL0_NDjAtuqBnBXqOCS-V-UfLPV3qS-gqQbhtztRAQvR-po7ychavWMGCPMx-1bFmFMItn_PO6L_oDYF7Hq8HhLO7Ap6GpfZ7J5aRr1UR__Y3F8T_7sge3t0CUzHrJ2YcdW9-Fm_3VlFf34MvruvYwlMjaEGnkGq0iWeJhEks2fV6tdWRZE9cpXMpxBFd0yfzdjDiMsY1vDGkbsm5c--Pb93W38vIe3nXKbnS3atzSkZU3NUSqGoHzKnC73ofzxasP89N4e0lDrKkf9pgraRkVRiZ5JoX0_j-niSqkyHOb20x5AKOESXOj0bhUyuMLa6Ymq4qKFcnU0AewWze1fQSkkNzYXEjKmGHKaKm04drQguk0lVxE8HSYrnLdc3GUQwzjR7AMIxjB4TCR5VYdXUmTsP1KWRHBk_GzVyTcHZG1bTosw7Mkw_grgoe9AIy1UO8zPNDjETwP0_j36suzj_Pw8Pjfix7AramHSn0a5SHstpvOHnmo06pjuDE7eXmyOA6y_RMgQ_8I |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEB_OE9EXvz-qp0bxwZcu7eajLfhyLB57enuI3MH5ICXJpLC4psu2Rc4n_wT_Rv8Sk3RbPEUQ30qbkjaZmfx-k8kMwItEp5UUqGNFMxYzoVmsKsFjWaFJBFKeV54oLo7F_JS9OeNnO_BqOAvT54cYHW5eM4K99gruHdK_aPnncz1JXQ_iElz2Fb0DoXo_Jo9ykhaKrXnKHmeOt2zzCvk4nvHVi6vRHxDzImINS87BDfg4fGwfafJp0rVqor_-lsfxf__mJlzfYlGy3wvPLdgx9jZc6atTnt-BL4fWOiRKpEUiUa69YSRLf57EkE0fWmsasrSk6ZT35jTEO3XJ7N0-aTzNRvc1pK3Jum7aH9--r7uVE_lwr1Nmo7tV3SwbsnLWhkhlPXZehfSud-H04PXJbB5v6zTEmqZUxFxJw6hAmeSZFNJBgJwmqpAiz01uMuUwjBKY5qi9famUgxgGp5hVRcWKZIr0Huza2poHQArJ0eRCUsaQKdRSaeQaacF0mkouIng-zFe57tNxlAONcSNYhhGMYG-YyXKrkU1Jk7ADS1kRwbPxsdMlv0Eirak734ZnSeYpWAT3ewkYe6Fu2XBYj0fwMszj37svFx9m4eLhvzd9ClfnJ4uj8ujw-O0juDZ1yKmPqtyD3XbTmccO-bTqSRDwn_DoAcA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9VAEB5qRfHFezVadRUffMkhOXvJhj6VUw-t2lLEQgUh7C1w8LgJJwlSn_wJ_Y39Jd3dnASrCOJbSDbMXmZmv5mdnQF4nai0FEyrWOKMxIQpEsuS0ViU2iRMY8pLbygeHrH9E_LulJ5uwM5wF6bPDzE63LxkBH3tBbzW5S9C_u1MTVJHgF2D64Ql3LP03scxd5RjtFBrzVvscebMlnVaIR_GM_56dTP6A2FeBaxhx5nfgS9DX_tAk6-TrpUT9eO3NI7_OZi7cHuNRNFuzzr3YMPY-3Cjr0159gC-H1jrcCgSViOhRe3VIlr42yQGrfrAWtOghUVNJ70vp0HepYtmx7uo8Ua2dp1BbYXqqmkvfp7X3dIxfHjXSbNS3bJqFg1aOl2DhLQeOS9DcteHcDJ_-2m2H6-rNMQKp5jFVApDMNMi4ZlgwgEAjhOZC8a54SaTDsFIplOuldcupXQAw-ipzsq8JHky1XgLNm1lzWNAuaDacCYwIZpIrYRUmiqNc6LSVFAWwathuYq6T8ZRDEaMm8EizGAE28NCFmt5bAqchPNXTPIIXo6fnST54xFhTdX5NjRLMm-ARfCoZ4CRCnabhkN6NII3YRn_Tr44_DwLD0_-vekLuHm8Ny8-HBy9fwq3pg429SGV27DZrjrzzMGeVj4P7H0JE9AAeA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Innate+and+adaptive+immune+responses+in+subjects+with+CPA+secondary+to+post-pulmonary+tuberculosis+lung+abnormalities&rft.jtitle=Mycoses&rft.au=Chirumamilla%2C+Naresh+Kumar&rft.au=Arora%2C+Kanika&rft.au=Kaur%2C+Mandeep&rft.au=Agarwal%2C+Ritesh&rft.date=2024-05-01&rft.issn=1439-0507&rft.eissn=1439-0507&rft.volume=67&rft.issue=5&rft.spage=e13746&rft_id=info:doi/10.1111%2Fmyc.13746&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0933-7407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0933-7407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0933-7407&client=summon |